MAPT and Alzheimer disease: In a rat model of Alzheimer’s disease (AD) induced by zinc injection, inhibition of mTOR by rapamycin attenuated zinc-induced tau phosphorylation and elevated levels of oxidative stress, as well as the synaptic impairment and decrease in cognitive function [8].